Overuse of Acid-Suppressive Therapy in Pediatric Patients
DOI:
https://doi.org/10.31052/1853.1180.v16.n1.6911Keywords:
Pediatrics, Pharmacoepidemiology, Drug Utilization, Stress Ulcer Prophylaxis, Medical Errors, Histamine H2 Antagonists, Proton Pump InhibitorsAbstract
Objectives: To evaluate prescription patterns of intravenous ranitidine and omeprazole in pediatric patients hospitalized in a children’s hospital, the adequacy of said prescriptions and the costs originated by incorrect prescriptions.
Patients and Methods: A study of medication usage was designed to observe all patients hospitalized at Hospital de Niños (Córdoba- Argentina) during one month.
Results: During the month of study 680 patients were hospitalized, 415 (61%) of them received acid-suppressive drugs (ASD). From these, 330 patients (79.5%) did not show risk factors to develop stress ulcer and indications were considered incorrect in 293 patients (70.6%). Only 81 patients (19.5%) showed correct indications and doses of ASD. A relationship was found between prescription and access to the operating room along with the concomitant use of corticoid in low doses. The unnecessary consumption of ASD generated a direct monthly expenditure of USD 470.42.
Conclusions: This study shows an alarming overuse of ASD in the pediatric population at Hospital de Niños. There exists a gap between scientific tests and everyday clinical practice in ASD use. Educational strategies should be implemented in pharmacotherapy using response protocols and pharmacology audits with posterior assessment to improve the use of medications and provide patients with an effective, safe, high-quality and academic medicine.
Downloads
Downloads
Issue
Section
License
Copyright (c) 2014 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).